We are live on ! Find out more
ZBH icon

Zimmer Biomet

966 hedge funds and large institutions have $18.8B invested in Zimmer Biomet in 2025 Q3 according to their latest regulatory filings, with 112 funds opening new positions, 325 increasing their positions, 336 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 67

7% more capital invested

Capital invested by funds: $17.6B → $18.8B (+$1.23B)

3% more funds holding

Funds holding: 934966 (+32)

0.65% less ownership

Funds ownership: 97.46%96.8% (-0.65%)

3% less repeat investments, than reductions

Existing positions increased: 325 | Existing positions reduced: 336

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

38% less call options, than puts

Call options by funds: $29.1M | Put options by funds: $47.1M

Holders
966
Holders Change
+32
Holders Change %
+3.43%
% of All Funds
12.68%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.08%
New
112
Increased
325
Reduced
336
Closed
67
Calls
$29.1M
Puts
$47.1M
Net Calls
-$17.9M
Net Calls Change
+$10.1M
Name Holding Trade Value Shares
Change
Change in
Stake
CB
326
Commerce Bank
Missouri
$1.54M -$133K -1,340 -8%
TRSOTSOK
327
Teachers Retirement System of the State of Kentucky
Kentucky
$1.53M
MSU
328
Mizuho Securities USA
New York
$1.53M +$74.1K +748 +5%
BIP
329
Brandes Investment Partners
California
$1.53M +$271K +2,730 +21%
CPBTD
330
Central Pacific Bank - Trust Division
Hawaii
$1.52M +$29.7K +300 +2%
Focus Partners Wealth
331
Focus Partners Wealth
Massachusetts
$1.51M -$591K -5,964 -28%
RBA
332
Richard Bernstein Advisors
New York
$1.5M -$1.84M -18,526 -55%
PAG
333
Private Advisor Group
New Jersey
$1.49M +$131K +1,319 +10%
BAM
334
Belpointe Asset Management
Nevada
$1.45M +$129K +1,300 +10%
Cambridge Investment Research Advisors
335
Cambridge Investment Research Advisors
Iowa
$1.42M +$574K +5,797 +67%
GAM
336
Generali Asset Management
Italy
$1.4M +$12.1K +122 +0.9%
PCP
337
Perbak Capital Partners
United Kingdom
$1.39M +$1.03M +10,439 +281%
Fifth Third Bancorp
338
Fifth Third Bancorp
Ohio
$1.39M -$168K -1,691 -11%
EI
339
Ethic Inc
New York
$1.38M +$776K +7,833 +126%
SCP
340
Sandhill Capital Partners
New York
$1.38M -$37.1K -374 -3%
CL
341
Choreo LLC
Illinois
$1.37M +$100K +1,010 +8%
MPI
342
Mairs & Power Inc
Minnesota
$1.37M -$32.2K -325 -2%
FWIA
343
Fort Washington Investment Advisors
Ohio
$1.37M +$2.28K +23 +0.2%
CIBC Private Wealth Group
344
CIBC Private Wealth Group
Georgia
$1.36M -$265K -2,676 -16%
NHC
345
Nicholas Hoffman & Company
Georgia
$1.3M -$194K -1,955 -13%
UBG
346
United Bank (Georgia)
Georgia
$1.27M +$100K +1,009 +8%
CNC
347
Citizens & Northern Corp
Pennsylvania
$1.27M -$5.95K -60 -0.5%
CIC
348
Crawford Investment Counsel
Georgia
$1.25M +$84.8K +856 +7%
VFA
349
Valeo Financial Advisors
Indiana
$1.25M +$30.1K +304 +2%
KeyBank National Association
350
KeyBank National Association
Ohio
$1.25M -$39.2K -396 -3%

ZBH Hedge Fund Activity: Q3 2025 in Review

966 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q3 2025, worth a combined $18.8B — up 7% from $17.6B a quarter earlier.

Buyers outnumbered sellers: 112 funds opened new ZBH positions and 67 closed out — a net gain of 45 holders — while 325 added to existing stakes and 336 trimmed.

The largest buyer was Dodge & Cox, adding an estimated $111M. The largest seller was Invesco, cutting an estimated $155M.

  • 966 institutional investors held Zimmer Biomet (ZBH) as of Q3 2025, up from 934 in Q2 2025.
  • Funds reported $18.8B of Zimmer Biomet stock for Q3 2025, up 7% quarter-over-quarter.
  • 112 funds opened new Zimmer Biomet positions in Q3 2025 and 67 closed out, a net change of +45 holders.
  • The largest Zimmer Biomet buyer in Q3 2025 was Dodge & Cox, an estimated $111M added.
  • The largest Zimmer Biomet seller in Q3 2025 was Invesco, an estimated $155M sold.

Based on aggregated 13F filings for Q3 2025.